Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017652 · ClinicalTrials.gov registry record
Validation of Fore-Sight Cerebral & Tissue Oximeter Saturation Measurements on Neonates ≤ 5 kg
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 19
- Enrollment target
NCT02017652: Completed study, sponsored by Sharp HealthCare.
NCT02017652 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02017652 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
CASMED, INC. wishes to validate the next generation FORE-SIGHT-II (FS-II) NIRS tissue oximeter monitor for neonatal brain and somatic tissue oxygen saturation (StO2) measurements. This monitor was recently FDA cleared for use on adult subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02017652
The ClinicalTrials.gov registry entry for NCT02017652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02017652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02017652 about?
NCT02017652 is a clinical study titled "Validation of Fore-Sight Cerebral & Tissue Oximeter Saturation Measurements on Neonates ≤ 5 kg". CASMED, INC. wishes to validate the next generation FORE-SIGHT-II (FS-II) NIRS tissue oximeter monitor for neonatal brain and somatic tissue oxygen saturation (StO2) measurements. This monitor was recently FDA cleared for use on adult subjects.
What is the current status of trial NCT02017652?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2013-12. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT02017652?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.